Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 305 (5681): 209-212

Copyright © 2004 by the American Association for the Advancement of Science

Exploiting Tolerance Processes in Transplantation

Herman Waldmann*, and Stephen Cobbold

Abstract: The full potential of organ transplantation has not yet been realized because of the hazards associated with the long-term use of immunosuppressive drugs. Modern research into mechanisms of immune tolerance offers the promise of reprogramming the immune system, so as to harness the body's natural tolerance mechanisms in the service of graft acceptance. This would allow the minimization of immunosuppressive treatment and offers the prospect of eventually weaning transplant recipients off their drugs.

Sir William Dunn School of Pathology, South Parks Road, Oxford OX13RE, UK.

* To whom correspondence should be addressed. E-mail herman.waldmann{at}path.ox.ac.uk


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Microchimerism in the Mother(land): Blurring the Borders of Body and Nation.
A. Martin (2010)
Body Society 16, 23-50
   Abstract »    PDF »
Antigen-Driven Interactions with Dendritic Cells and Expansion of Foxp3+ Regulatory T Cells Occur in the Absence of Inflammatory Signals.
P. Chappert, M. Leboeuf, P. Rameau, D. Stockholm, R. Liblau, O. Danos, J. M. Davoust, and D.-A. Gross (2008)
J. Immunol. 180, 327-334
   Abstract »    Full Text »    PDF »
Double-Negative T Cells, Activated by Xenoantigen, Lyse Autologous B and T Cells Using a Perforin/Granzyme-Dependent, Fas-Fas Ligand-Independent Pathway.
Z.-X. Zhang, Y. Ma, H. Wang, J. Arp, J. Jiang, X. Huang, K. M. He, B. Garcia, J. Madrenas, and R. Zhong (2006)
J. Immunol. 177, 6920-6929
   Abstract »    Full Text »    PDF »
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products.
D.-A. Gross, P. Chappert, M. Leboeuf, V. Monteilhet, L. Van Wittenberghe, O. Danos, and J. Davoust (2006)
Blood 108, 1841-1848
   Abstract »    Full Text »    PDF »
CD4+ regulatory cells as a potential immunotherapy.
Z. Fehervari and S. Sakaguchi (2005)
Phil Trans R Soc B 360, 1647-1661
   Abstract »    Full Text »    PDF »
Immunomodulation of Atherosclerosis: Implications for Vaccine Development.
J. Nilsson, G. K. Hansson, and P. K. Shah (2005)
Arterioscler Thromb Vasc Biol 25, 18-28
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882